Trials / Unknown
UnknownNCT05000060
Restart TICrH AP Pilot Trial
A Prospective Randomized Open-Label Blinded Endpoint (PROBE) Pilot Trial of Early Restarting Antiplatelet Therapy Versus Usual Care After Traumatic Intracranial Hemorrhage.
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- University of Texas at Austin · Academic / Other
- Sex
- All
- Age
- 55 Years
- Healthy volunteers
- Not accepted
Summary
A Prospective Randomized Open-Label Blinded Endpoint (PROBE) Pilot Trial of restarting antiplatelet therapy at 1 week versus 3 weeks after traumatic intracranial hemorrhage with a primary composite endpoint of major bleeding and vascular occlusive events.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Timing/1 week | Time of restart of antiplatelet therapy is one week after injury |
| OTHER | Timing/3 weeks | Time of restart of antiplatelet therapy is left to treating clinician discretion |
Timeline
- Start date
- 2022-10-01
- Primary completion
- 2023-10-01
- Completion
- 2023-10-01
- First posted
- 2021-08-11
- Last updated
- 2021-10-07
Source: ClinicalTrials.gov record NCT05000060. Inclusion in this directory is not an endorsement.